Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

RNAi company OliX lists in Korea

Jaime De Leon
July 20, 2018 4:43 PM UTC

OliX Pharmaceuticals Inc. (KOSDAQ:226950) raised KrW43.2 billion ($38.3 million) on July 18 through the sale of 1.2 million shares at KrW36,000 in an IPO underwritten by NH Investment & Securities.

Next half, OliX expects to complete a U.K. Phase I trial of OLX10010 to treat hypertrophic scars. The RNA interference therapeutic targets connective tissue growth factor (CTGF)...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Olix Pharmaceuticals Inc.